131 related articles for article (PubMed ID: 38679211)
1. Overexpression of soluble epoxide hydrolase reduces post-ischemic recovery of cardiac contractile function.
Edin ML; Gruzdev A; Bradbury JA; Graves JP; Muse GW; Goulding DR; Lih FB; DeGraff LM; Zeldin DC
Biochem Pharmacol; 2024 Apr; ():116237. PubMed ID: 38679211
[TBL] [Abstract][Full Text] [Related]
2. Disruption of Ephx2 in cardiomyocytes but not endothelial cells improves functional recovery after ischemia-reperfusion in isolated mouse hearts.
Edin ML; Gruzdev A; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Fleming I; Zeldin DC
J Biol Chem; 2023 Apr; 299(4):103049. PubMed ID: 36822325
[TBL] [Abstract][Full Text] [Related]
3. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.
Seubert JM; Sinal CJ; Graves J; DeGraff LM; Bradbury JA; Lee CR; Goralski K; Carey MA; Luria A; Newman JW; Hammock BD; Falck JR; Roberts H; Rockman HA; Murphy E; Zeldin DC
Circ Res; 2006 Aug; 99(4):442-50. PubMed ID: 16857962
[TBL] [Abstract][Full Text] [Related]
4. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.
Edin ML; Hamedani BG; Gruzdev A; Graves JP; Lih FB; Arbes SJ; Singh R; Orjuela Leon AC; Bradbury JA; DeGraff LM; Hoopes SL; Arand M; Zeldin DC
J Biol Chem; 2018 Mar; 293(9):3281-3292. PubMed ID: 29298899
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice.
Hoopes SL; Gruzdev A; Edin ML; Graves JP; Bradbury JA; Flake GP; Lih FB; DeGraff LM; Zeldin DC
PLoS One; 2017; 12(4):e0175348. PubMed ID: 28384353
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
[TBL] [Abstract][Full Text] [Related]
7. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells.
Katragadda D; Batchu SN; Cho WJ; Chaudhary KR; Falck JR; Seubert JM
J Mol Cell Cardiol; 2009 Jun; 46(6):867-75. PubMed ID: 19285984
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.
Koerner IP; Jacks R; DeBarber AE; Koop D; Mao P; Grant DF; Alkayed NJ
J Neurosci; 2007 Apr; 27(17):4642-9. PubMed ID: 17460077
[TBL] [Abstract][Full Text] [Related]
10. Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
PLoS One; 2017; 12(1):e0169584. PubMed ID: 28056085
[TBL] [Abstract][Full Text] [Related]
11. Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury.
Strauss KI; Gruzdev A; Zeldin DC
Prostaglandins Other Lipid Mediat; 2013; 104-105():18-24. PubMed ID: 22922090
[TBL] [Abstract][Full Text] [Related]
12. Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids.
Zhao C; Jiang X; Peng L; Zhang Y; Li H; Zhang Q; Wang Y; Yang F; Wu J; Wen Z; He Z; Shen J; Chen C; Wang DW
J Mol Cell Cardiol; 2023 Dec; 185():13-25. PubMed ID: 37871528
[TBL] [Abstract][Full Text] [Related]
13. Deletion of soluble epoxide hydrolase attenuates mice Hyperoxic acute lung injury.
Liu LP; Li B; Shuai TK; Zhu L; Li YM
BMC Anesthesiol; 2018 Apr; 18(1):48. PubMed ID: 29703148
[TBL] [Abstract][Full Text] [Related]
14. sEH promotes macrophage phagocytosis and lung clearance of Streptococcus pneumoniae.
Li H; Bradbury JA; Edin ML; Graves JP; Gruzdev A; Cheng J; Hoopes SL; DeGraff LM; Fessler MB; Garantziotis S; Schurman SH; Zeldin DC
J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34591792
[TBL] [Abstract][Full Text] [Related]
15. Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function.
Chaudhary KR; Batchu SN; Das D; Suresh MR; Falck JR; Graves JP; Zeldin DC; Seubert JM
Cardiovasc Res; 2009 Jul; 83(2):362-70. PubMed ID: 19401302
[TBL] [Abstract][Full Text] [Related]
16. Soluble epoxide hydrolase and ischemic cardiomyopathy.
Zhao TT; Wasti B; Xu DY; Shen L; Du JQ; Zhao SP
Int J Cardiol; 2012 Mar; 155(2):181-7. PubMed ID: 21704394
[TBL] [Abstract][Full Text] [Related]
17. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.
Chen G; Xu R; Wang Y; Wang P; Zhao G; Xu X; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E563-75. PubMed ID: 22739108
[TBL] [Abstract][Full Text] [Related]
18. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
19. Genetic Deletion or Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Cardiac Ischemia/Reperfusion Injury by Attenuating NLRP3 Inflammasome Activation.
Darwesh AM; Keshavarz-Bahaghighat H; Jamieson KL; Seubert JM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31319469
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase: a new target for cardioprotection.
Gross GJ; Nithipatikom K
Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]